洛穆斯丁和普雷迪尼索隆作为第一线治疗犬多中心淋巴瘤的使用
Chiara Catalucci1, Marco Luigi Bianchi2, Elisabetta Treggiari3
1Oncology Service, Clinica Veterinaria Malpensa AniCura, Samarate, Italy.
Veterinary and comparative oncology
|June 19, 2024
概括
单剂慕斯和普雷迪尼索隆化疗治疗犬类淋巴瘤的反应率为87%,但与多剂方案相比,生存时间更短,这表明息效用有限.
科学领域:
- 兽医瘤学 兽医瘤学
- 狗癌症研究 狗癌症研究
- 淋巴瘤的治疗方法
背景情况:
- 多剂化学疗法是犬类高级淋巴瘤的标准.
- 由于成本和时间的限制,正在探索单个代理协议.
- 洛穆斯丁和普雷迪尼索隆是潜在的单剂选择.
研究的目的:
- 评估作为一线治疗犬多中心淋巴瘤的洛穆斯丁和普雷迪尼索隆的疗效和预后因素.
- 为了确定反应率,进展时间,无病间隔和生存时间.
主要方法:
- 对30只患有中大细胞多中心淋巴瘤的狗进行了回顾性研究,这些狗接受了Lomustine和Prednisolone治疗.
- 分析对治疗的反应,进展时间 (TTP),中位数无病间隔 (MDFI) 和中位数存活时间 (MST).
- 研究预后因素,包括临床阶段.
主要成果:
- 总体应答率 (RR) 为87% (50%完全缓解, 37%部分缓解).
- 平均TTP,MDFI和MST分别为42,63和90天.
- 临床阶段是MDFI和MST的唯一重要的预后因素.
结论:
- 在多中心淋巴瘤的狗中,洛穆斯和普雷迪尼索隆治疗导致反应率和存活时间较低,而不是与多剂方案相比.
- 短暂的反应表明该方案的效用有限,主要用于息.
- 对最佳单剂或组合疗法的进一步研究是有必要的.
相关概念视频
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Lymphoid Cells and Tissues
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...


